Home » ALLERGAN 3Q PROFIT BEATS ESTIMATES
ALLERGAN 3Q PROFIT BEATS ESTIMATES
Allergan Inc., maker of eye care products and the Botox wrinkle injection, said
Tuesday that its third-quarter profit jumped 64 percent. The results beat Wall
Street estimates. The company also raised its guidance for 2005, sending its
shares up $2.14, or 2.4 percent, to $91.44 in morning trading on the New York
Stock Exchange. The stock has traded between $69.01 and $95.43 over the past
year.
Yahoo News
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May